Erythrodermic psoriasis after discontinuation of ixekizumab Kathryn Anne Potter, MD, Kiran Motaparthi, MD, Jennifer J. Schoch, MD JAAD Case Reports Volume 4, Issue 1, Pages 22-23 (January 2018) DOI: 10.1016/j.jdcr.2017.06.026 Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Exfoliative erythroderma on bilateral lower extremities. JAAD Case Reports 2018 4, 22-23DOI: (10.1016/j.jdcr.2017.06.026) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Exfoliative erythroderma of face. JAAD Case Reports 2018 4, 22-23DOI: (10.1016/j.jdcr.2017.06.026) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
Fig 3 Classic features of psoriasis are seen, including regular epidermal hyperplasia, hypogranulosis, dilated vessels within the dermal papillae, and numerous neutrophils in the stratum corneum and epidermis. (A and B, Hematoxylin-eosin stain; original magnifications: A, ×100; B, ×200.) JAAD Case Reports 2018 4, 22-23DOI: (10.1016/j.jdcr.2017.06.026) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions